Novozymes A/S
NSIS-B
Rang in Aktien
#821
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Aktienkurs
$71.08
Marktkapitalisierung
$29.32B
Veränderung (1 Tag)
1.13%
Veränderung (1 Jahr)
11.94%
Land
DK
Handel Novozymes A/S (NSIS-B)
Kategorie
Basic Materials
Anzahl der ausstehenden Aktien von Novozymes A/S (NSIS-B)
Anzahl der ausstehenden Aktien zum October 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Novozymes A/S beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von October 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Novozymes A/S (NSIS-B) von 2002 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2025 | 414.56M | -9.41% |
| 2024 | 457.62M | 65.19% |
| 2023 | 277.04M | 0.14% |
| 2022 | 276.64M | -0.46% |
| 2021 | 277.92M | -0.89% |
| 2020 | 280.43M | -1.64% |
| 2019 | 285.11M | -1.83% |
| 2018 | 290.42M | -1.66% |
| 2017 | 295.34M | -1.71% |
| 2016 | 300.47M | -1.81% |
| 2015 | 306.00M | -1.89% |
| 2014 | 311.90M | -0.59% |
| 2013 | 313.76M | -0.07% |
| 2012 | 313.98M | -0.37% |
| 2011 | 315.16M | 0.63% |
| 2010 | 313.18M | 0.94% |
| 2009 | 310.27M | 0.30% |
| 2008 | 309.35M | -0.07% |
| 2007 | 309.57M | -1.53% |
| 2006 | 314.37M | -3.95% |
| 2005 | 327.31M | -4.12% |
| 2004 | 341.38M | -3.10% |
| 2003 | 352.30M | -2.59% |
| 2002 | 361.68M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 462.53M | - |
GB
|
|
| - | - |
FR
|
|
| 244.80M | - |
US
|
|
| 281.30M | - |
US
|
|
| 222.80M | - |
US
|
